Heterozygous mutations cause a paradoxical thrombocytosis characterized by high TPO level in plasma due to incomplete cell surface expression of c‐MPL in mature cells and increased stimulation of Stem/progenitors population with optimal expression of c‐MPL. This evidence concerns the gene TPO and thrombocytosis disease.